Why Would a Doctor Prescribe Farxiga? Beyond Diabetes Management
•
3 min read
According to the landmark DAPA-CKD trial, Farxiga demonstrated a significant 39% reduction in the risk of worsening renal function or cardiovascular death in patients with chronic kidney disease. Consequently, a doctor would prescribe Farxiga for an expanding range of conditions, leveraging its protective effects on multiple organ systems beyond its initial indication for diabetes.
